Dr. Julie E. Lang, MD is Chief of Breast Surgery, Hillcrest Hospital and Director of the Eastern Region Breast Cancer Program of Cleveland Clinic. She is a Principal Investigator in the Department of Cancer Biology of the Lerner Research Institute. She earned her Doctor of Medicine from the University of North Carolina, Chapel Hill in 1999. She completed a fellowship in Breast Surgical Oncology at the UT-MD Anderson Cancer Center. Her residency training and postdoctoral fellowship were completed at the University of California, San Francisco. Her research interests include liquid biopsy, translational genomics, biomarkers, and clinical trials in breast cancer. She is a surgeon-scientist who specializes in clinical-translational research aimed at improving the treatment of breast cancer. Her laboratory was one of the first to report the feasibility of the RNA sequencing of circulating tumor cells (CTCs). Prior to joining Cleveland Clinic, she served as an Associate Professor of Surgery at the University of Southern California and as an Assistant Professor at the University of Arizona. She is a member of the Society of Surgical Oncology, the American Society of Breast Surgeons, and the American Association of Cancer Research.